Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
The stem bark extract of afforded a previously undescribed -abietane diterpenoid trivially named mangiolide () and a known jolkinolide B () via anticancer bioassay-guided fractionation. The CHCl:MeOH extract of was initially analysed for its anticancer properties against three cancer cell lines, renal (TK10), melanoma (UACC62), and breast (MCF7) and was found to be potent at low μg/mL ranges. Compound , 6α-acetoxy-14-keto--abieta-7(8),13(15)-diene-16,12-olide (mangiolide) inhibited the growth of renal (TK10) with a GI of 0.02 μg/mL; a GI of 0.03 μg/mL for melanoma (UACC62) and a GI of 0.05 μg/mL for breast (MCF7) cancer cell lines. Compound , 8,13-diepoxy-13,15--abietene-16,12-olide (jolkinolide B) inhibited the growth (GI) of the cell lines at 3.31 μg/mL for renal (TK10), 0.94 μg/mL for melanoma (UACC62) and 2.99 μg/mL for the breast (MCF7). The structures were established on the basis of their spectroscopic analysis and the absolute stereostructures assigned using electronic circular dichroism (ECD).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/14786419.2018.1470628 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!